A randomised phase II study of chemoradiotherapy with or without nimotuzumab in locally advanced oesophageal cancer: NICE trial.
Sign Up to like & getrecommendations! Published in 2018 at "European journal of cancer"
DOI: 10.1016/j.ejca.2017.10.005
Abstract: PURPOSE Chemoradiotherapy is the standard treatment for patients with inoperable locally advanced oesophageal cancer. We sought to assess the safety and efficacy of chemoradiation combined with nimotuzumab, a humanised antibody directed against epidermal growth factor… read more here.
Keywords: chemoradiotherapy; without nimotuzumab; cancer; locally advanced ... See more keywords
Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients Treated with Definitive Chemoradiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Management and Research"
DOI: 10.2147/cmar.s395191
Abstract: Background The neutrophil-to-lymphocyte ratio (NLR) has been shown to have prognostic value in several common cancers. This study aimed to investigate the prognostic value of NLR in patients with advanced oesophageal squamous cell carcinoma (ESCC)… read more here.
Keywords: oesophageal squamous; lymphocyte ratio; advanced oesophageal; value ... See more keywords
Pre-treatment CRP and Albumin Determines Prognosis for Unresectable Advanced Oesophageal Cancer
Sign Up to like & getrecommendations! Published in 2022 at "In Vivo"
DOI: 10.21873/invivo.12914
Abstract: Background/Aim: Nutritional disorders due to cancer-related weight loss, such as cancer-impaired food passage, are prominent in many cases of advanced oesophageal cancer. Here, we investigated the nutritional factors that most affect the therapeutic effect and… read more here.
Keywords: prognosis; advanced oesophageal; pre treatment; oesophageal cancer ... See more keywords